SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
Neuromodulation companies are keeping their fingers crossed that the positive growth in Q123 is a sign t...
The Centers for Medicare and Medicaid Services (CMS) projects Medicare home health spending in the US wi...
Strong returns in IM Nailing and a flurry of activity in the Pediatric space results in a healthy Q123 f...
SmartTRAK’s survey of interventional pain physicians reveals valuable insights into current and future t...
Despite M&A uncertainties with Orthofix/SeaSpine and Globus/NuVasive, the Spine market posted strong...
Orahn Preiss-Bloom, founder and Chief Innovation Officer of Ossio Ltd. discusses Osssio’s advancements i...
SmartTRAK reports from the EWMA conference in Italy, where cold plasma companies are hoping to work toge...
Soft Tissue Fixation Rebounds in Q123 To Start the Year In a Positive Direction In Q1, the STF market ex...
In addition to product innovation and increasing adoption, the Spine Enabling Technology market is rapid...
SmartTRAK highlights cutting-edge advances in non-fusion technologies and motion-preserving treatments p...
Login